Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 539 Neoplasms 482 Carcinoma, Non-Small-Cell Lung 395 Prostatic Neoplasms 314 Colorectal Neoplasms 300 Lung Neoplasms 265 Neoplasm Metastasis 222 Ovarian Neoplasms 199 Leukemia, Myeloid, Acute 197 Pancreatic Neoplasms 187 Multiple Myeloma 174 Recurrence 135 Squamous Cell Carcinoma of Head and Neck 133 Stomach Neoplasms 131 Brain Neoplasms 131 Melanoma 127 Carcinoma, Hepatocellular 126 Glioblastoma 121 Endometrial Neoplasms 121 Triple Negative Breast Neoplasms 113 Precursor Cell Lymphoblastic Leukemia-Lymphoma 106 Hematologic Neoplasms 104 Head and Neck Neoplasms 100 Carcinoma, Renal Cell 98 Lymphoma 96 Urinary Bladder Neoplasms 93 Sarcoma 91 Glioma 88 Rectal Neoplasms 83 Small Cell Lung Carcinoma 82

Interventions

Tablets 1 Genetic Testing 1 Everolimus 1 Blood Specimen Collection 1 Biomarkers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Hormone Receptor Positive Breast Cancer × 90 days × Clear all

NCT07646171 2026-06-12

MBC

Tel-Aviv Sourasky Medical Center

Hormone Receptor Positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡